0001183765 false 0001183765 2023-10-27 2023-10-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): October 27, 2023

 

 

Molecular Templates, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32979   94-3409596

(State or other jurisdiction of

incorporation or organization)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

 

9301 Amberglen Blvd, Suite 100

Austin, Texas 78729

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (512) 869-1555

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

symbol(s)

  

Name of each exchange

on which registered

Common Stock, $0.001 par value per share   MTEM   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On October 27, 2023, Molecular Templates, Inc. (the “Company”) held its 2023 annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, a quorum of 3,862,824 shares of the Company’s common stock, or 71.88% of the outstanding shares of common stock entitled to vote as of the record date of September 7, 2023, were present in person or represented by proxy. At the Annual Meeting, the stockholders: (1) elected each of Eric E. Poma, Ph.D., Harold E. Selick, Ph.D., and Gabriela Gruia, M.D. to the Company’s Board of Directors as a Class I director for a term of three years to serve until the 2026 annual meeting of stockholders and until his or her successor is elected and qualified or until his or her earlier death, resignation or removal (“Election of Directors”); (2) ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 (“Auditor Ratification”); and (3) approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement for the meeting (“Advisory Vote on Executive Compensation”). A more complete description of each of these matters is set forth in the Company’s proxy statement.

 

The number of votes cast in favor or against by the stockholders and the number of abstentions and the number of broker non-votes on each of the foregoing matters are set forth below.

 

1. Election of Directors

 

Nominee   Shares
Voted For		   Shares
Voted
Against		   Shares
Abstaining		   Broker
Non-votes
Eric E. Poma, Ph.D.   3,067,904   13,761   962   780,197
Harold E. Selick, Ph.D.   2,747,329   334,259   1,039   780,197
Gabriela Gruia, M.D.   3,062,159   19,470   998   780,197

 

2. Auditor Ratification

 

Shares
Voted For		   Shares
Voted
Against		   Shares
Abstaining
3,797,660   3,354   61,810

 

3. Advisory Vote on Executive Compensation

 

Shares
Voted For		   Shares
Voted
Against		   Shares
Abstaining		   Broker
Non-votes
3,057,877   23,433   1,317   780,197

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Molecular Templates, Inc.
     
Dated: October 27, 2023    
     
    By: /s/ Eric E. Poma, Ph.D.
      Name: Eric E. Poma, Ph.D.
      Title: Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

v3.23.3
Cover
Oct. 27, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 27, 2023
Entity File Number 001-32979
Entity Registrant Name Molecular Templates, Inc.
Entity Central Index Key 0001183765
Entity Tax Identification Number 94-3409596
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 9301 Amberglen Blvd
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Austin
Entity Address, State or Province TX
Entity Address, Postal Zip Code 78729
City Area Code (512)
Local Phone Number 869-1555
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol MTEM
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Molecular Templates (NASDAQ:MTEM)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more Molecular Templates Charts.
Molecular Templates (NASDAQ:MTEM)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more Molecular Templates Charts.